Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Plant

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Genome Medicine|September 5, 2018
Increased DNA methylation variability in rheumatoid arthritis-discordant monozygotic twinsAmy P Webster, Darren Plant, Simone Ecker, et al.
Rheumatology Advances in Practice|January 5, 2026
Patterns of steroid use in patients with established rheumatoid arthritis commencing treatment with biologic or targeted synthetic DMARDsMichael Stadler, Shae Bindra, Annie Cheung, et al.
Annals of the Rheumatic Diseases|February 22, 2023
Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysisSamantha Louise Smith, Sheree Alexander, Nisha Nair, et al.
Rheumatology (Oxford, England)|May 13, 2025
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritisStephanie F Ling, Chuan Fu Yap, Nisha Nair, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between <i>IL18RAP</i> expression and treatment responseSvetlana Cherlin, Myles J Lewis, Darren Plant, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid ArthritisDarren Plant, Amy Webster, Nisha Nair, et al.
The Journal of Rheumatology|June 15, 2023
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK CohortPhilippa D K Curry, Hector Chinoy, Meghna Jani, et al.
Plos One|March 31, 2012
Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritisMarcus Ronninger, Maria Seddighzadeh, Morten Christoph Eike, et al.
The Journal of Rheumatology|December 18, 2012
Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damageSebastien Viatte, Darren Plant, Mark Lunt, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Genome Medicine|September 5, 2018
Increased DNA methylation variability in rheumatoid arthritis-discordant monozygotic twinsAmy P Webster, Darren Plant, Simone Ecker, et al.
Rheumatology Advances in Practice|January 5, 2026
Patterns of steroid use in patients with established rheumatoid arthritis commencing treatment with biologic or targeted synthetic DMARDsMichael Stadler, Shae Bindra, Annie Cheung, et al.
Annals of the Rheumatic Diseases|February 22, 2023
Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysisSamantha Louise Smith, Sheree Alexander, Nisha Nair, et al.
Rheumatology (Oxford, England)|May 13, 2025
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritisStephanie F Ling, Chuan Fu Yap, Nisha Nair, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between <i>IL18RAP</i> expression and treatment responseSvetlana Cherlin, Myles J Lewis, Darren Plant, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid ArthritisDarren Plant, Amy Webster, Nisha Nair, et al.
The Journal of Rheumatology|June 15, 2023
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK CohortPhilippa D K Curry, Hector Chinoy, Meghna Jani, et al.
Plos One|March 31, 2012
Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritisMarcus Ronninger, Maria Seddighzadeh, Morten Christoph Eike, et al.
The Journal of Rheumatology|December 18, 2012
Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damageSebastien Viatte, Darren Plant, Mark Lunt, et al.
Pageof 11